Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Acceleron Pharma Sees Prelim. Q3 Royalty Revenues ~$19.3M From ~$96M In Net Sales Of Reblozyl


Benzinga | Nov 5, 2020 07:30AM EST

Acceleron Pharma Sees Prelim. Q3 Royalty Revenues ~$19.3M From ~$96M In Net Sales Of Reblozyl






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC